ondansetron has been researched along with Craniosynostoses in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Craniosynostoses: Premature closure of one or more CRANIAL SUTURES. It often results in plagiocephaly. Craniosynostoses that involve multiple sutures are sometimes associated with congenital syndromes such as ACROCEPHALOSYNDACTYLIA; and CRANIOFACIAL DYSOSTOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Villedieu, E | 1 |
| Robinson, W | 1 |
| Shales, C | 1 |
1 other study available for ondansetron and Craniosynostoses
| Article | Year |
|---|---|
Suspected Obstructive Sleep Apnea Successfully Treated with Ondansetron in a Pug.
Topics: Airway Obstruction; Animals; Craniosynostoses; Dog Diseases; Dogs; Ondansetron; Sleep Apnea, Obstruc | 2022 |